Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed consent for BRCA1 and BRCA2 testing.

B K Rimer1, J Sugarman, E Winer

  • 1Duke University Medical Center, Cancer Control Research Program, Trent Drive, Hanes House, Box 2949, Durham, NC 27710, USA.

Breast Disease
|February 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).

Breast cancer research : BCR·2025
Same author

Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Erratum to "Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Prevalence and mutational determinants of high tumor mutation burden in breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same journal

Paget disease of the breast: An often-overlooked malignancy.

Breast disease·2026
Same journal

Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Breast disease·2025
Same journal

Association between AKT1 polymorphisms and susceptibility to breast cancer in the Iranian population.

Breast disease·2025
Same journal

Circulating tumor cells as a clinical, diagnostic, and prognostic biomarker in breast cancer.

Breast disease·2025
Same journal

Isolated breast myeloid sarcoma: A diagnostic and therapeutic challenge. A case report and literature review.

Breast disease·2025
Same journal

Imaging evaluation of nipple discharge: Review of literature and management considerations.

Breast disease·2025
See all related articles

Genetic testing for BRCA1 and BRCA2 offers hope but raises concerns. This review addresses informed consent challenges and provides recommendations for cancer genetic testing and research.

Area of Science:

  • Genetics
  • Oncology
  • Bioethics

Background:

  • The cloning of BRCA1 and BRCA2 genes sparked enthusiasm for cancer patients and families.
  • Concerns exist regarding the informed consent process for genetic testing.
  • Previous research on informed consent for other diseases offers insights but cancer-specific issues are more complex.

Purpose of the Study:

  • To review the background of informed consent in genetic testing.
  • To summarize studies on genetic testing, focusing on BRCA1 and BRCA2.
  • To detail recommendations for informed consent in cancer susceptibility testing and research.

Main Methods:

  • Literature review of studies on genetic testing and informed consent.
  • Focus on BRCA1 and BRCA2 genetic testing.
Keywords:
Genetics and Reproduction

Related Experiment Videos

  • Analysis of recommendations from major health organizations.

    • Main Results:

    • While recommendations exist, many questions about informed consent for cancer genetic testing remain unanswered.
    • Specific issues related to cancer susceptibility testing require careful consideration.
    • Existing research provides a foundation but further work is needed.

    Conclusions:

    • Achieving adequate informed consent for cancer genetic testing is crucial.
    • Recommendations are provided to improve the informed consent process.
    • Further research is needed to address remaining challenges in cancer genetics research informed consent.